// App-Quantinova.ai

P027 : Immune checkpoint inhibitor associated vasculitis: a limitation to cancer therapy

Researchers

Presenter

  • Marcus Au

Principal Investigators

  • Anissa Faher

  • Ei Ei Phyu Htut

Medical Centers

  • Department of Haematology, Cambridge University Hospitals, Cambridge, United Kingdom

  • University of Cambridge School of Clinical Medicine, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Ophthalmology (OP)

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Mesothelioma

  • Pulmonary alveolar proteinosis

  • Sarcoidosis

  • Solid malignancies

  • Cataract 6, multiple types

Biomarkers

  • Bone Morphogenetic Protein 1

  • EPH Receptor A2

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisolone

  • dalteparin Subcutaneous

  • Sildenafil citrate

  • Nivolumab

  • Iloprost

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved